Published by Frank Prenesti on 12th August 2022
(Sharecast News) - AstraZeneca and Daiichi Sankyo's Enhertu drug has been approved in the US for the treatment of adult patients with unresectable or metastatic non-small cell lung cancer, the companies said on Friday.
URL: http://www.digitallook.com/dl/news/story/32888390/...